These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Separation and purefied of calf osteocalcin, set up radioimmunoassay for osteocalcin]. Kong Y, Meng X, Zhou X, Liu H, Liu S. Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1997 Aug; 19(4):257-62. PubMed ID: 10453563 [Abstract] [Full Text] [Related]
7. [Osteocalcin, a marker in diseases with elevated bone metabolism]. Stracke H, Schatz C, Pralle H, Ullmann J, Schatz H. Dtsch Med Wochenschr; 1985 Sep 20; 110(38):1442-6. PubMed ID: 3875469 [Abstract] [Full Text] [Related]
8. Serum osteocalcin levels in normal subjects and patients with primary hyperparathyroidism. Ljunghall S, Hällgren R, Rastad J. Exp Clin Endocrinol; 1985 Dec 20; 86(2):218-22. PubMed ID: 3879222 [Abstract] [Full Text] [Related]
12. Serum osteocalcin (BGP) in tumor-associated hypercalcemia. Body JJ, Cleeren A, Pot M, Borkowski A. J Bone Miner Res; 1986 Dec 20; 1(6):523-7. PubMed ID: 3509743 [Abstract] [Full Text] [Related]
13. Serum osteocalcin in primary hyperparathyroidism: short-term effect of surgery. Minisola S, Scarnecchia L, Scarda A, Bigi F, Tabolli S, Valtorta C, Mazzuoli G. Miner Electrolyte Metab; 1988 Dec 20; 14(4):201-7. PubMed ID: 3264876 [Abstract] [Full Text] [Related]
14. Plasma osteocalcin in man. Melick RA, Farrugia W, Quelch KJ. Aust N Z J Med; 1985 Aug 20; 15(4):410-6. PubMed ID: 3878701 [Abstract] [Full Text] [Related]
15. Effect of acute increases in bone matrix degradation on circulating levels of bone-Gla protein. Riggs BL, Tsai KS, Mann KG. J Bone Miner Res; 1986 Dec 20; 1(6):539-42. PubMed ID: 3509744 [Abstract] [Full Text] [Related]
16. Serum osteocalcin, bone alkaline phosphatase isoenzyme and plasma tartrate resistant acid phosphatase in patients on chronic maintenance hemodialysis. Stĕpán JJ, Lachmanová J, Straková M, Pacovský V. Bone Miner; 1987 Nov 20; 3(2):177-83. PubMed ID: 3509796 [Abstract] [Full Text] [Related]
17. Changes in plasma bone GLA protein during treatment of bone disease. Deftos LJ, Parthemore JG, Price PA. Calcif Tissue Int; 1982 Mar 20; 34(2):121-4. PubMed ID: 6805917 [Abstract] [Full Text] [Related]
18. Clinical assessment of collagen cross-linked N-telopeptides as a marker of bone metabolism in patients with primary hyperparathyroidism. Takami H, Ikeda Y, Hayashi K, Hayashi M, Konishi K, Saruta T, Carpi A. Biomed Pharmacother; 1999 Aug 20; 53(7):329-33. PubMed ID: 10472434 [Abstract] [Full Text] [Related]
19. Clinical evaluation of bone turnover by serum osteocalcin measurements in a hospital setting. Slovik DM, Gundberg CM, Neer RM, Lian JB. J Clin Endocrinol Metab; 1984 Aug 20; 59(2):228-30. PubMed ID: 6610686 [Abstract] [Full Text] [Related]
20. Determinants of bone gamma-carboxyglutamic acid-containing protein in plasma of healthy aging subjects. Catherwood BD, Marcus R, Madvig P, Cheung AK. Bone; 1985 Aug 20; 6(1):9-13. PubMed ID: 3873250 [Abstract] [Full Text] [Related] Page: [Next] [New Search]